Pages that link to "Q80387209"

The following pages link to SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery (Q80387209):

Displaying 50 items.

• The human DEK oncogene regulates DNA damage response signaling and repair (Q24306086) (← links)
• Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer (Q26783559) (← links)
• Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation (Q26858894) (← links)
• Solution NMR structure of the N-terminal domain of the human DEK protein (Q27649727) (← links)
• iTRAQ proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells (Q33401743) (← links)
• Regulating Set-β's Subcellular Localization Toggles Its Function between Inhibiting and Promoting Axon Growth and Regeneration. (Q33639540) (← links)
• Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type (Q33980633) (← links)
• Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases (Q33990380) (← links)
• High-Affinity Interaction of Poly(ADP-ribose) and the Human DEK Oncoprotein Depends upon Chain Length (Q34090063) (← links)
• Control of tumorigenesis and chemoresistance by the DEK oncogene (Q34096933) (← links)
• The 3'-5' DNA exonuclease TREX1 directly interacts with poly(ADP-ribose) polymerase-1 (PARP1) during the DNA damage response (Q34552582) (← links)
• The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity (Q34762745) (← links)
• The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers (Q34765982) (← links)
• DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. (Q34991689) (← links)
• Melanoma proliferation and chemoresistance controlled by the DEK oncogene (Q34997265) (← links)
• DEK expression in melanocytic lesions. (Q35182702) (← links)
• The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation (Q35250786) (← links)
• Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer. (Q35362468) (← links)
• Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility (Q35735221) (← links)
• Epigenetic regulation of axon and dendrite growth (Q35791723) (← links)
• The N-terminal Set-β Protein Isoform Induces Neuronal Death (Q35861000) (← links)
• Eviction of linker histone H1 by NAP-family histone chaperones enhances activated transcription (Q36022891) (← links)
• Regulation of chromatin structure by poly(ADP-ribosyl)ation (Q36204365) (← links)
• Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression (Q36485156) (← links)
• Is there an epigenetic component underlying the resistance of triple-negative breast cancers to parp inhibitors? (Q36490203) (← links)
• Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status (Q36524257) (← links)
• Stacking the DEK: from chromatin topology to cancer stem cells (Q36604651) (← links)
• DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress (Q36710870) (← links)
• Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation (Q36842905) (← links)
• DEK proto-oncogene expression interferes with the normal epithelial differentiation program. (Q37073767) (← links)
• Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo (Q37116215) (← links)
• Nuclear pore proteins and cancer (Q37252910) (← links)
• Beyond DNA Repair: Additional Functions of PARP-1 in Cancer (Q37346306) (← links)
• PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis (Q37377750) (← links)
• The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets (Q37770152) (← links)
• Concise review: role of DEK in stem/progenitor cell biology (Q38111687) (← links)
• The DEK oncoprotein and its emerging roles in gene regulation (Q38375804) (← links)
• Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription (Q39076617) (← links)
• A role for intracellular and extracellular DEK in regulating hematopoiesis (Q39184178) (← links)
• DEK over-expression promotes mitotic defects and micronucleus formation. (Q39986963) (← links)
• SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation (Q41809641) (← links)
• A histone chaperone, DEK, transcriptionally coactivates a nuclear receptor. (Q41827108) (← links)
• The Oncogenic Fusion Proteins SET-Nup214 and Sequestosome-1 (SQSTM1)-Nup214 Form Dynamic Nuclear Bodies and Differentially Affect Nuclear Protein and Poly(A)+ RNA Export. (Q42725755) (← links)
• A DEK domain-containing protein modulates chromatin structure and function in Arabidopsis (Q45814467) (← links)
• The nuclear DEK interactome supports multi-functionality. (Q47589392) (← links)
• The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. (Q49219370) (← links)
• Development and identification of Set transgenic mice (Q49751447) (← links)
• Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence. (Q52656023) (← links)
• Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto clusters causing aberrant expression in leukemia cells (Q83226904) (← links)
• DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung (Q84395876) (← links)